Avoid common mistakes on your manuscript.
Correction: American Journal of Cardiovascular Drugs (2024) 24:197–209 https://doi.org/10.1007/s40256-024-00634-8
In this article the corporate e-mail address of the corresponding author dora.molina@ucaldas.edu.co should have been included.
In the Acknowledgements, Funding and Conflicts of Interest section of this article the funder name was incorrectly given as Tecnimede - Sociedade Técnico Medicinal, S.A. and should have been Altadis/Group Tecnimede.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Molina de Salazar, D.I., Coca, A., Alcocer, L. et al. Correction: The Rationale for Using Fixed‑Dose Combination Therapy in the Management of Hypertension in Colombia: A Narrative Review. Am J Cardiovasc Drugs (2024). https://doi.org/10.1007/s40256-024-00656-2
Published:
DOI: https://doi.org/10.1007/s40256-024-00656-2